Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Argus Health
Federal Trade Commission
Queensland Health
AstraZeneca
Medtronic
Fuji
Healthtrust
Farmers Insurance

Generated: January 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020934

« Back to Dashboard

NDA 020934 describes LUXIQ, which is a drug marketed by Mylan Pharms Inc and is included in one NDA. It is available from two suppliers. Additional details are available on the LUXIQ profile page.

The generic ingredient in LUXIQ is betamethasone valerate. There are sixty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 020934
Tradename:LUXIQ
Applicant:Mylan Pharms Inc
Ingredient:betamethasone valerate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020934
Medical Subject Heading (MeSH) Categories for 020934
Suppliers and Packaging for NDA: 020934
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8180 0378-8180-50 50 g in 1 CAN (0378-8180-50)
LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8180 0378-8180-99 100 g in 1 CAN (0378-8180-99)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.12%
Approval Date:Feb 28, 1999TE:ABRLD:Yes

Expired US Patents for NDA 020934

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934-001 Feb 28, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Mallinckrodt
Chubb
Daiichi Sankyo
Moodys
Covington
Queensland Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.